
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening
Xiaofei Chen, Yun‐Long Wu, Chun Chen, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 1, pp. 222-236
Open Access | Times Cited: 153
Xiaofei Chen, Yun‐Long Wu, Chun Chen, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 1, pp. 222-236
Open Access | Times Cited: 153
Showing 26-50 of 153 citing articles:
Quality and composition control of complex TCM preparations through a novel “Herbs-in vivo Compounds-Targets-Pathways” network methodology: the case of Lianhuaqingwen capsules
Simian Chen, Hui Qi, Chunyan Zhu, et al.
Pharmacological Research (2025), pp. 107650-107650
Open Access
Simian Chen, Hui Qi, Chunyan Zhu, et al.
Pharmacological Research (2025), pp. 107650-107650
Open Access
Trace component fishing strategy based on offline two-dimensional liquid chromatography combined with PRDX3-surface plasmon resonance for Uncaria alkaloids
Ni Hui, Zijia Zhang, Ye Lu, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101244-101244
Open Access
Ni Hui, Zijia Zhang, Ye Lu, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101244-101244
Open Access
Research Progress and Challenges of Molecular Recognition Techniques in the Screening of Active Ingredients in Traditional Chinese Medicine
Lin Li, Qi Li, Yanxiao Li, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101243-101243
Open Access
Lin Li, Qi Li, Yanxiao Li, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101243-101243
Open Access
Comparative two-dimensional NKG2A/CD94 cell membrane chromatography system for targeted screening immune checkpoint inhibitors
Yanting Li, Yanqiu Gu, Weiyue Zhang, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101259-101259
Open Access
Yanting Li, Yanqiu Gu, Weiyue Zhang, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101259-101259
Open Access
A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor
Murat Öz, Dietrich E. Lorke, Nadine Kabbani
Pharmacology & Therapeutics (2020) Vol. 221, pp. 107750-107750
Open Access | Times Cited: 41
Murat Öz, Dietrich E. Lorke, Nadine Kabbani
Pharmacology & Therapeutics (2020) Vol. 221, pp. 107750-107750
Open Access | Times Cited: 41
Therapeutic Effects and Molecular Mechanisms of Bioactive Compounds Against Respiratory Diseases: Traditional Chinese Medicine Theory and High-Frequency Use
Jing Wang, Qibiao Wu, Lu Ding, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 38
Jing Wang, Qibiao Wu, Lu Ding, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 38
Probiotics and prebiotics: potential prevention and therapeutic target for nutritional management of COVID-19?
Kamila Sabino Batista, Juliana Gondim de Albuquerque, Maria Helena Araújo de Vasconcelos, et al.
Nutrition Research Reviews (2021) Vol. 36, Iss. 2, pp. 181-198
Open Access | Times Cited: 36
Kamila Sabino Batista, Juliana Gondim de Albuquerque, Maria Helena Araújo de Vasconcelos, et al.
Nutrition Research Reviews (2021) Vol. 36, Iss. 2, pp. 181-198
Open Access | Times Cited: 36
Can Antiviral Activity of Licorice Help Fight COVID-19 Infection?
Luisa Diomede, Marten Beeg, A. Gamba, et al.
Biomolecules (2021) Vol. 11, Iss. 6, pp. 855-855
Open Access | Times Cited: 33
Luisa Diomede, Marten Beeg, A. Gamba, et al.
Biomolecules (2021) Vol. 11, Iss. 6, pp. 855-855
Open Access | Times Cited: 33
Screening S protein – ACE2 blockers from natural products: Strategies and advances in the discovery of potential inhibitors of COVID-19
Le-le Ma, Huimin Liu, Xuemei Liu, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113857-113857
Open Access | Times Cited: 33
Le-le Ma, Huimin Liu, Xuemei Liu, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113857-113857
Open Access | Times Cited: 33
Composition, Clinical Efficiency, and Mechanism of NHC-Approved “Three Chinese Medicines and Three Chinese Recipes” for COVID-19 Treatment
Ke-Yao Xia, Zeyuan Zhao, Taif Shah, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 26
Ke-Yao Xia, Zeyuan Zhao, Taif Shah, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 26
Glycyrrhizin as a promising kryptonite against SARS-CoV-2: Clinical, experimental, and theoretical evidences
Suvankar Banerjee, Sandip Kumar Baidya, Nilanjan Adhikari, et al.
Journal of Molecular Structure (2022) Vol. 1275, pp. 134642-134642
Open Access | Times Cited: 25
Suvankar Banerjee, Sandip Kumar Baidya, Nilanjan Adhikari, et al.
Journal of Molecular Structure (2022) Vol. 1275, pp. 134642-134642
Open Access | Times Cited: 25
Identification of potential anti-pneumonia pharmacological components of Glycyrrhizae Radix et Rhizoma after the treatment with Gan An He Ji oral liquid
Xiaojuan Jiang, Lin Yi-Hua, Yun‐Long Wu, et al.
Journal of Pharmaceutical Analysis (2022) Vol. 12, Iss. 6, pp. 839-851
Open Access | Times Cited: 24
Xiaojuan Jiang, Lin Yi-Hua, Yun‐Long Wu, et al.
Journal of Pharmaceutical Analysis (2022) Vol. 12, Iss. 6, pp. 839-851
Open Access | Times Cited: 24
Synergistic deciphering of bioenergy production and electron transport characteristics to screen traditional Chinese medicine (TCM) for COVID-19 drug development
Po‐Wei Tsai, Cheng-Yang Hsieh, Jasmine U. Ting, et al.
Journal of the Taiwan Institute of Chemical Engineers (2022) Vol. 135, pp. 104365-104365
Open Access | Times Cited: 23
Po‐Wei Tsai, Cheng-Yang Hsieh, Jasmine U. Ting, et al.
Journal of the Taiwan Institute of Chemical Engineers (2022) Vol. 135, pp. 104365-104365
Open Access | Times Cited: 23
Skullcapflavone II, a novel NQO1 inhibitor, alleviates aristolochic acid I-induced liver and kidney injury in mice
Yaping Dong, Shuzhen Chen, Huisi He, et al.
Acta Pharmacologica Sinica (2023) Vol. 44, Iss. 7, pp. 1429-1441
Open Access | Times Cited: 13
Yaping Dong, Shuzhen Chen, Huisi He, et al.
Acta Pharmacologica Sinica (2023) Vol. 44, Iss. 7, pp. 1429-1441
Open Access | Times Cited: 13
The phytochemistry, pharmacology, pharmacokinetics, quality control, and toxicity of Forsythiae Fructus: An updated systematic review
Jinjin Li, Zihao Chen, Chengjun Liu, et al.
Phytochemistry (2024) Vol. 222, pp. 114096-114096
Closed Access | Times Cited: 4
Jinjin Li, Zihao Chen, Chengjun Liu, et al.
Phytochemistry (2024) Vol. 222, pp. 114096-114096
Closed Access | Times Cited: 4
Progress in Traditional Chinese Medicine Against Respiratory Viruses: A Review
B. Li, Zhongyuan Li, Miao Liu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 31
B. Li, Zhongyuan Li, Miao Liu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 31
Regulation of m6A Methylation as a New Therapeutic Option against COVID-19
Carla Zannella, Luca Rinaldi, Giovanni Boccia, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 11, pp. 1135-1135
Open Access | Times Cited: 31
Carla Zannella, Luca Rinaldi, Giovanni Boccia, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 11, pp. 1135-1135
Open Access | Times Cited: 31
Potential Treatment of COVID-19 with Traditional Chinese Medicine: What Herbs Can Help Win the Battle with SARS-CoV-2?
Lin Li, Yuzheng Wu, Jiabao Wang, et al.
Engineering (2021) Vol. 19, pp. 139-152
Open Access | Times Cited: 30
Lin Li, Yuzheng Wu, Jiabao Wang, et al.
Engineering (2021) Vol. 19, pp. 139-152
Open Access | Times Cited: 30
Chemical profiling of Huashi Baidu prescription, an effective anti-COVID-19 TCM formula, by UPLC-Q-TOF/MS
Wenlong Wei, Shifei Wu, Haojv Li, et al.
Chinese Journal of Natural Medicines (2021) Vol. 19, Iss. 6, pp. 473-480
Open Access | Times Cited: 27
Wenlong Wei, Shifei Wu, Haojv Li, et al.
Chinese Journal of Natural Medicines (2021) Vol. 19, Iss. 6, pp. 473-480
Open Access | Times Cited: 27
Roles of the gut microbiota in severe SARS-CoV-2 infection
Yiran Liu, Dan Kuang, Dan Li, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 63, pp. 98-107
Open Access | Times Cited: 21
Yiran Liu, Dan Kuang, Dan Li, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 63, pp. 98-107
Open Access | Times Cited: 21
Traditional Chinese Medicines Against COVID-19
Chang-Liang Yao, Wenlong Wei, Jian-Qing Zhang, et al.
World Journal of Traditional Chinese Medicine (2022) Vol. 8, Iss. 3, pp. 279-313
Open Access | Times Cited: 19
Chang-Liang Yao, Wenlong Wei, Jian-Qing Zhang, et al.
World Journal of Traditional Chinese Medicine (2022) Vol. 8, Iss. 3, pp. 279-313
Open Access | Times Cited: 19
Research and development of Chinese anti-COVID-19 drugs
Xiwei Ji, Xiangrui Meng, Xiao Zhu, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 12, pp. 4271-4286
Open Access | Times Cited: 19
Xiwei Ji, Xiangrui Meng, Xiao Zhu, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 12, pp. 4271-4286
Open Access | Times Cited: 19
Precise assembly of inside-out cell membrane camouflaged nanoparticles via bioorthogonal reactions for improving drug leads capturing
Xiaolin Zhang, Xueyan Zhen, Yixuan Yang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 2, pp. 852-862
Open Access | Times Cited: 18
Xiaolin Zhang, Xueyan Zhen, Yixuan Yang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 2, pp. 852-862
Open Access | Times Cited: 18
Development of SARS-CoV-2 entry antivirals
Meiyue Dong, Jazmin Galván Achi, Ruikun Du, et al.
Cell Insight (2024) Vol. 3, Iss. 1, pp. 100144-100144
Open Access | Times Cited: 3
Meiyue Dong, Jazmin Galván Achi, Ruikun Du, et al.
Cell Insight (2024) Vol. 3, Iss. 1, pp. 100144-100144
Open Access | Times Cited: 3
Structure of Polysaccharide from Dendrobium nobile Lindl. and Its Mode of Action on TLR4 to Exert Immunomodulatory Effects
Lian Li, Hang Chen, Guichun Huang, et al.
Foods (2024) Vol. 13, Iss. 9, pp. 1356-1356
Open Access | Times Cited: 3
Lian Li, Hang Chen, Guichun Huang, et al.
Foods (2024) Vol. 13, Iss. 9, pp. 1356-1356
Open Access | Times Cited: 3